CDMO Samsung Biologics’ Executives Stress Speed and Innovation With Plant 5 Ahead of Schedule
Samsung Biologics, the largest contract development and manufacturing organizations (CDMOs) by capacity in the world, recently announced that its fifth biomanufacturing plant will be completed in April 2025. Work on…